PDS Biotechnology Corp Capital Expenditures Incurred but Not yet Paid
PDS Biotechnology Corp (PDSB) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2018-11-01
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for the quarter ending 2018-09-30 was $0.00.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for the quarter ending 2017-12-31 was -$18.08K.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for the quarter ending 2017-09-30 was -$37.01K.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for the quarter ending 2017-06-30 was $55.09K, a 89.52% decline year-over-year.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for fiscal 2016 was $167.28K, a 135.48% increase from fiscal 2015.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for fiscal 2015 was $71.04K, a 84.23% decline from fiscal 2014.
- PDS Biotechnology Corp capital expenditures incurred but not yet paid for fiscal 2014 was $450.37K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | -$18.08K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$55.09K derived: sum of 2 quarters · filed 2018-11-01 | $0.00 derived: sum of 3 quarters · filed 2018-11-01 | $0.00 10-K · filed 2018-03-01 |
| 2017-09-30 | -$37.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $18.08K derived: sum of 2 quarters · filed 2018-11-01 | $18.08K 10-Q · filed 2018-11-01 | -$163.22K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $55.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $55.09K 10-Q · filed 2018-08-01 | -$126.22K derived: sum of 3 quarters · filed 2018-08-01 | -$308.13K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 | -$181.31K derived: sum of 2 quarters · filed 2018-03-01 | -$363.21K derived: sum of 3 quarters · filed 2018-03-01 | $162.28K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-12-31 | -$181.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$363.21K derived: sum of 2 quarters · filed 2018-03-01 | $162.28K derived: sum of 3 quarters · filed 2018-03-01 | $167.28K 10-K · filed 2018-03-01 |
| 2016-09-30 | -$181.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $343.59K derived: sum of 2 quarters · filed 2017-11-01 | $348.59K 10-Q · filed 2017-11-01 | -$157.21K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $525.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $530.50K 10-Q · filed 2017-08-01 | $24.70K derived: sum of 3 quarters · filed 2018-03-01 | $334.57K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $5.00K 10-Q · filed 2017-05-03 | -$500.80K derived: sum of 2 quarters · filed 2018-03-01 | -$190.93K derived: sum of 3 quarters · filed 2018-03-01 | -$6.98K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$505.80K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$195.93K derived: sum of 2 quarters · filed 2018-03-01 | -$11.98K derived: sum of 3 quarters · filed 2018-03-01 | $71.04K 10-K · filed 2018-03-01 |
| 2015-09-30 | $309.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $493.82K derived: sum of 2 quarters · filed 2016-11-01 | $576.84K 10-Q · filed 2016-11-01 | $661.23K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $183.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $266.97K 10-Q · filed 2016-08-03 | $351.36K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $83.02K 10-Q · filed 2016-05-03 | $167.41K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $84.39K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $450.37K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $365.98K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |